China Universal Asset Management Company’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
SCM
China Universal Asset Management Company's PRAX Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Praxis Precision Medicines (PRAX) stake by 10% in Q2 2026, selling an estimated $160K and leaving 4,437 shares worth $1.49M. The position accounts for 0.09% of the portfolio, ranked #165.
China Universal Asset Management Company first reported a position in PRAX in Q3 2022 and has held it in 8 quarters since. The position peaked at $1.59M in Q1 2026. 138 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.
- China Universal Asset Management Company held 4,437 shares of Praxis Precision Medicines worth $1.49M as of Q2 2026.
- China Universal Asset Management Company sold 505 Praxis Precision Medicines shares in Q2 2026, an estimated $160K.
- Praxis Precision Medicines made up 0.09% of China Universal Asset Management Company's portfolio in Q2 2026, its #165 holding.
- China Universal Asset Management Company first reported a position in Praxis Precision Medicines in Q3 2022 and has held it in 8 quarters since.
- China Universal Asset Management Company's Praxis Precision Medicines position peaked at $1.59M in Q1 2026.
- 138 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.